Hormone therapy for preventing cardiovascular disease in post-menopausal women
University of Oxford · John Radcliffe Hospital · +11 more institutions
Abstract
Evidence from systematic reviews of observational studies suggests that hormone therapy may have beneficial effects in reducing the incidence of cardiovascular disease events in post-menopausal women, however the results of randomised controlled trials (RCTs) have had mixed results. This is an updated version of a Cochrane review published in 2013.
To assess the effects of hormone therapy for the prevention of cardiovascular disease in post-menopausal women, and whether there are differential effects between use in primary or secondary prevention. Secondary aims were to undertake exploratory analyses to (i) assess the impact of time since menopause that treatment was commenced (≥ 10 years versus
Citation impact
- FWCI
- 32.64
- Percentile
- 100%
- References
- 243
Authors
8- HBHenry BoardmanCorresponding
University of Oxford, John Radcliffe Hospital
- LHLouise Hartley
University of Warwick
- AEAnne Eisinga
Cochrane, National Institute for Health Research
- CMCaroline Main
University of Birmingham, Cancer Research UK Clinical Trials Unit
- MRMarta Roqué i Figuls
Iberoamerican Cochrane Centre, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
Topics & keywords
- Medicine
- Observational study
- Cochrane Library
- Hormone therapy
- Placebo
- Meta-analysis
- Randomized controlled trial
- MEDLINE
- Good health and well-being